GoodRx Holdings, Inc. ( GDRX) - Key Metrics
GDRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.59 | $0.03 | $0.24 | $0.30 |
| 2026Q1 | $0.57 | $0 | $0.03 | -$0.03 |
| 2025Q4 | $0.57 | $0.02 | $0.10 | $0.05 |
| 2025Q3 | $0.56 | $0 | $0.22 | $0.17 |
| 2025Q2 | $0.57 | $0.04 | $0.14 | $0.09 |
GDRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 24 |
| 2026Q1 | 0% | 144.12 |
| 2025Q4 | 0% | 42.34 |
| 2025Q3 | 0% | 330.47 |
| 2025Q2 | 0% | 34.58 |
GDRX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 10.33% | 0% |
| 2026Q1 | -1.47% | 0% |
| 2025Q4 | 1.85% | 0% |
| 2025Q3 | 3.94% | 0% |
| 2025Q2 | 1.76% | 0% |
GDRX
Price: $3.39
52 week price:
Earnings Per Share: 0.06 USD
P/E Ratio: 63.33
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Country: United States
Volume: 1.5 million
Market Capitalization: 1.2 billion